Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Expects OTC Switch Self-Selection Studies To Probe Consumer Thinking

This article was originally published in The Tan Sheet

Executive Summary

A draft guidance on designing self-selection studies in support of Rx-to-OTC switches reflects FDA’s interest in drilling down for greater insight into consumers’ thought processes.
Advertisement

Related Content

FDA Self-Selection Study Guidance Calls For Complex Questions
FDA Self-Selection Study Guidance Calls For Complex Questions
FDA Self-Selection Study Guidance Calls For Complex Questions
OTC Switch “Blueprint” Could Help Regulatory Navigation – Researchers
Self-Selection Studies Need Room To Evaluate Purchase Decisions – Expert
The Future Of OTCs: Self-Selection Meets Diagnostics, Genetic Personalization
CDER Director Sees Behind-The-Counter Switches As Best Bet
Merck’s Mevacor Switch Bid Digs Deeper Into Consumers’ Self-Selection
Merck’s Mevacor Switch Bid Digs Deeper Into Consumers’ Self-Selection
NDAC Panelists Look At Future Of Behavior Research For OTC Postmarket

Topics

Advertisement
UsernamePublicRestriction

Register

PS105298

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel